FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

49722008: Somatostatin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
82812011 Somatotropin release inhibiting factor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
82813018 Somatostatin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
82814012 Growth hormone inhibiting factor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
787432017 Somatostatin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1230764012 Growth hormone release inhibiting hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1230765013 SS - Somatostatin en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
2670919019 Somatostatin-14 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
56491000195112 somatostatina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
841611000172118 somatostatine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
71491000195117 Somatostatin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Somatostatin Is a Gastrointestinal hormone true Inferred relationship Some
Somatostatin Is a Hypothalamic inhibiting factor true Inferred relationship Some
Somatostatin Is a Peptide hormones and their metabolites and precursors false Inferred relationship Some
Somatostatin This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Hypothalamic inhibiting factor (disposition) true Inferred relationship Some
Somatostatin Is a Peptide hormone true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Octreotide Is a False Somatostatin Inferred relationship Some
Somatostatin-14 Is a False Somatostatin Inferred relationship Some
Somatostatin-28 Is a False Somatostatin Inferred relationship Some
Somatostatin measurement (procedure) Has measured component (attribute) False Somatostatin Inferred relationship Some
Somatostatin antigen Direct substance False Somatostatin Inferred relationship Some
Serum somatostatin measurement Has measured component (attribute) False Somatostatin Inferred relationship Some
Somatostatin measurement (procedure) Component True Somatostatin Inferred relationship Some 1
Serum somatostatin measurement Component False Somatostatin Inferred relationship Some 2
Lanreotide 30mg powder and solvent for injection suspension vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Lanreotide acetate 38mg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Plasma somatostatin level (procedure) Component False Somatostatin Inferred relationship Some 2
Product containing somatostatin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Somatostatin Inferred relationship Some 1
Product containing somatostatin analog (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide 50micrograms/mL injection solution 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide 100micrograms/mL injection solution 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide 500micrograms/mL injection solution 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide 200micrograms/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide 10mg powder and solvent for injection suspension vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide 20mg powder and solvent for injection suspension vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide 30mg powder and solvent for injection suspension vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Product containing lanreotide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Product containing octreotide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide acetate preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Lanreotide 60mg/0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Lanreotide 90mg/0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Lanreotide 120mg/0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide acetate 20mg depot injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide acetate 10mg depot injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide acetate 30mg depot injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide acetate 1mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide acetate 100mcg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide acetate 200mcg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide acetate 500mcg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide acetate 50mcg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Lanreotide acetate 30mg/vial injection suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide 1mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Octreotide 1mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Product containing octreotide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Lanreotide 30mg powder and solvent for injection suspension vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Product containing somatostatin analog (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatostatin Inferred relationship Some
Somatostatin acetate (substance) Is a False Somatostatin Inferred relationship Some
Somatostatin acetate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Somatostatin Inferred relationship Some
Somatostatin-28 This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Somatostatin Inferred relationship Some
Product containing only somatostatin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Somatostatin Inferred relationship Some 1
Plasma somatostatin level (procedure) Component True Somatostatin Inferred relationship Some 1
Serum somatostatin measurement Component True Somatostatin Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start